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Abstract
The retinal activity for vision requires a precise syn-
aptic connectivity. Shank proteins at postsynaptic 
sites of excitatory synapses play roles in signal trans-
mission into the postsynaptic neuron. However, the 
correlation of Shank 2 expression with neuronal differ-
entiation in the developing retina remains to be eluci-
dated regardless of previous evidences of Shank 2 ex-
pression in retina. Herein, we demonstrated that with 
progression of development, Shank 2 is initially de-
tected in the inner plexiform layer at P2, and then in-
tensively detected in inner plexiform layer, outer plexi-
form layer, and ganglion cell layer at P14, which was 
closely colocalized to the neurofilament expression. 
Shank 2 was, however, not colocalized with glial fibril-
lary acidic protein. Shank 2 expression was increased 
in the differentiated retinoblastoma cells, which was 
mediated by ERK 1/2 activation. Moreover, Shank 2 ex-
pression was colocalized with neurofilament at the 
dendritic region of cells. In conclusion, our data sug-
gests that Shank 2 is expressed in the neurons of the 
developing retina and could play a critical role in the 
neuronal differentiation of the developing retina.
Keywords: cell differentiation; extracellular signal- 
regulated MAP kinases; neurons; retina; SHANK 2 
protein, human
Introduction
The retinal activity for vision requires a precise 
synaptic connectivity and an appropriate balance 
between excitatory and inhibitory synapses. The 
retina is well-organized into three distinct nuclear 
layers containing neuronal cell bodies and two 
distinct plexiform layers of synaptic contacts. The 
visual signals proceed through the nuclear layers, 
which are delivered and modulated by extensive 
synapses within the plexiform layers.
    The proper functioning of the neuronal networks 
is regulated by the balance in excitatory and 
inhibitory synapses between two neurons with 
intrinsic properties (MacLean et al., 2003; Turri-
giano et al., 2004). The most of these synapses 
occur at contacts between presynaptic axons and 
postsynaptic dendrites, which predominantly use 
glutamate as the excitatory neurotransmitter. In the 
excitatory synapses, cardinal components of the 
postsynaptic specialization including glutamate re-
ceptors are gathered in a structure known as the 
postsynaptic density (PSD) (Sheng, 2001).
    Of PSD proteins, Shank is a scaffold protein to 
contain a PDZ domain that binds to the C terminus 
of PSD-95-associated protein GKAP, a proline-rich 
region that binds to cortactin, and a SAM domain 
that mediates multimerization (Naisbitt et al., 1999). 
Shank 1, Shank 2, and Shank 3 constitute a family 
of proteins, which can be generated by alternative 
splicing or different assignments of translational 
start site (Lim et al., 1999). The Shank proteins are 
differentially expressed in different regions and at 
different developmental stages. Shank 1 and Shank 
2 are mainly expressed in brain and Shank 3 is 
abundant in heart and moderate in brain and 
spleen (Lim et al., 1999; Yao et al., 1999). Shank 
proteins expressed in early developmental stages 
are related to the development of central nervous 
systems (Petralia et al., 2005). In addition, Shank 
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Figure 1. Shank 2 expression in the 
developing retina. In the developing 
retina at P2, P4, P8, and P14, retinal 
sections of 2 disc diameter su-
pero-temporal from the optic disc in 
the developing retina were evalua-
ted. The immunohistochemistry for 
Shank 2 (red) was performed, and 
nuclei were labeled (blue) with 
DAPI. Each figure is representative 
ones from six independent expe-
riments. GCL, ganglion cell layer; 
IPL, inner plexiform layer; INL, inner 
nuclear layer; OPL, outer plexiform 
layer; ONL, outer nuclear layer; RBL, 
retinoblast layer. Scale bar, 200 μm.
has been known to function as a molecular scaffold 
to induce the neuronal differentiation and synap-
togenesis (Sala et al., 2001; Roussignol et al., 
2005; Gerrow et al., 2006). Although it was reported 
that Shank 2 is expressed in retina synapses 
(Brandsta ̈tter et al., 2004), the correlation of Shank 
2 expression with neuronal differentiation in the 
developing retina remains to be elucidated.
    Herein, we demonstrated Shank 2 is expressed 
in the developing retina, which is related to the 
neuronal differentiation. Shank 2 was colocalized 
with neurofilament of neuronal differentiation marker, 
but not with glial fibrillary acidic protein (GFAP) of 
an astrocyte-specific marker. In addition, Shank 2 
was up-regulated with neuronal differentiation me-
diated by ERK 1/2 activation, which was also 
colocalized with neurofilament at the dendritic 
region of the differentiated retinoblastoma cells. 
Therefore, our data suggests that Shank 2 may 
play a critical role in the neuronal differentiation of 
the developing retina.
Results
Shank 2 expression in the developing retina
To investigate Shank 2 expression in the develo-
ping retina, fluorescence immunohistochemistry 
was performed (Figure 1). In normal retina of 
mouse, just after birth, the retina is composed of 
two layers of neuronal cells (ganglion cell layer, 
GCL and retinoblast layer, RBL) and one plexiform 
layer between nuclear layers. At P2, Shank 2 was 
detected in GCL including nerve fiber layer and 
IPL, where the synapses of ganglion cells, bipolar 
cells and amacrine cells are mainly formed. With 
differentiation of retina, RBL differentiates into two 
layers of inner nuclear layer, INL, and outer nuclear 
layer, ONL. From P3-4, the retina has three nu-
clear layer of GCL, INL, and ONL, and two plexi-
form layers of inner plexiform layer, IPL, and outer 
plexiform layer, OPL (Vecino et al., 2004). At P4, 
Shank2 was also detected in IPL and the newly 
dividing region which would later become OPL, 
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Figure 2. Colocalization of Shank 2 
with neurofilament in the developing 
retina. In the developing retina at 
P2, P4, P8, and P14, retinal sec-
tions of 2 disc diameter supero-tem-
poral from the optic disc in the de-
veloping retina were evaluated. The 
immunohistochemistry for Shank 2 
(red) and neurofilament (green) was 
performed. Each figure is repre-
sentative ones from six independent 
experiments. GCL, ganglion cell lay-
er; IPL, inner plexiform layer; INL, 
inner nuclear layer; OPL, outer 
plexiform layer; ONL, outer nuclear 
layer; RBL, retinoblast layer. Scale 
bar, 200 μm.
where the most synapses of photoreceptor, hori-
zontal cells, and bipolar cells are formed. At P8, 
when three distinct nuclear layers and two distinct 
plexiform layers were almost divided, Shank 2 was 
intensively expressed in IPL and OPL. At P14, 
Shank 2 was also strongly expressed in GCL, as 
well as IPL and OPL. Also, shank2 was expressed 
in inner or outer segments of photoreceptor. These 
results suggest that Shank 2 expression might be 
related to neuronal differentiation in the developing 
retina.
Colocalization of Shank 2 with neurofilament in the 
developing retina
To address the correlation of Shank 2 expression 
with neuronal differentiation in developing retina, 
colocalization of Shank 2 with neurofilament, a 
neuronal differentiation marker, was evaluated by 
double immunofluorescence staining (Figure 2). At 
P2, neurofilament was detected mainly in GCL and 
IPL, and freckly within RBL, where would be OPL. 
With differentiation of retina, from P4, neurofila-
ment was also detected in OPL as well as IPL and 
GCL. Interestingly, Shank 2 was colocalized with 
neurofilament through all the development stages. 
Although shank2 staining is very diffuse in all 
retinal layers, shank2 is colocalized with neuro-
filament. It seems that shank2 expresses basically 
in the retina and it is strongly localized in the 
dendrites regions. Considered that neurofilament is 
to be critical in neuronal differentiation, these 
results suggest that Shank 2 might be involved in 
neuronal differentiation in the developing retina.
Shank 2 expression in the retinal astrocytes
In the central nervous system including brain and 
retina, the astrocyte regulates synaptic transmi-
ssion and neurovascular coupling, as same as the 
neuronal cell (Haydon et al., 2006). Therefore, we 
checked whether Shank 2 is also expressed in the 
retinal astrocyte (Figure 3). Shank 2 was detected 
in IPL, OPL, and GCL, whereas GFAP, an astro-
cyte marker, was detected only in the outermost 
region of GCL. However, Shank 2 was not colo-
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Figure 4. Shank 2 expression in neuronal differentiation via ERK 1/2 activation. SNUOT-Rb1 cells were treated with 10 μM retinoic acid or 50 μM 
PD98059, a specific inhibitor of MEK-1. Shank 2, neurofilament, ERK 1/2 and phosphor-ERK 1/2 were detected by Western blotting analysis. Data are 
representative of at least three independent experiments. β-actin was served as a loading control.
Figure 3. Shank 2 expression in the 
retinal astrocytes. In the developing 
retina on P14, retinal sections of 2 
disc diameter supero-temporal from 
the optic disc in the developing reti-
na were evaluated. The immunohis-
tochemistry for Shank 2 (red), neu-
rofilament (green), and GFAP (green) 
was performed. Each figure is repre-
sentative ones from six independent 
experiments. GCL, ganglion cell lay-
er; IPL, inner plexiform layer; INL, 
inner nuclear layer; OPL, outer ple-
xiform layer; ONL, outer nuclear 
layer. Scale bar, 500 μm.
calized with GFAP in GCL. Theses data indicate 
that Shank 2 is primarily expressed in neuronal 
cells rather than astrocytes of the retina.
Shank 2 expression in neuronal differentiation via 
ERK 1/2 activation
To determine whether Shank 2 expression is rela-
ted to the neuronal differentiation via ERK 1/2 acti-
vation, we assessed Shank 2 expression in diffe-
rentiated retinoblastoma cells treated with all-trans 
retinoic acid (Kim et al., 2007a) and addressed the 
relationship with ERK 1/2 activation (Jung et al., 
2006). As shown in Figure 4A, with treatment of 
all-trans retinoic acid (10 μM) in SNUOT-Rb1 cells, 
the expression of neurofilament and Shank 2 were 
increased together. To confirm the relationship of 
Shank 2 expression with neuronal differentiation 
via ERK 1/2 activation, we investigate whether the 
inhibition of ERK 1/2 blocks the differentiation of 
retinoblastoma cells (Figure 4B). With treatment of 
all-trans retinoic acid, Shank 2 expression was 
increased, which was accompanied by the phos-
phorylations of ERK1/2. SNUOT-Rb1 cells treated 
with 50 μM PD98059, an inhibitor of MEK-1, and 
10 μM all-trans retinoic acid inhibited the phospho-
rylation of ERK 1/2 and the expression of Shank 2. 
These data suggest that Shank 2 expression is 
related to the neuronal differentiation via ERK 1/2 
activation.
Colocalization of Shank 2 with neurofilament at the 
contacts of outgrowing neurites
To investigate the localization of Shank 2 in the 
differentiated retinoblastoma cells, we performed 
immunocytochemistry for Shank2 and neurofila-
ment (Figure 5). While Shank 2 was diffusely 
expressed around the nucleus in the undifferen-
tiated cells, it was strongly expressed at the con-
tacts of outgrowing neuritis in the differentiated 
cells. Interestingly, Shank 2 was colocalized with 
neurofilament in the differentiated retinoblastoma 
cells, as similar as in the developing retina (Figure 
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Figure 5. Colocalization of Shank 2 with neurofilament at the contacts of outgrowing neuritis. SNUOT-Rb1 cells were treated with 10μM retinoic acid. 
Neuronal differentiation with retinoic acid was addressed by the morphological changes of neurite extensions. The immunocytochemistry for Shank 2 (red) 
and neurofilament (green) was performed, and nuclei were labeled (blue) with DAPI. Arrows indicate the colocalization of Shank 2 and neurofilament at 
the dendritic region of cells. Each figure is representative ones from six independent experiments. Scale bar, 10 μm.
2). These data provide that Shank 2 increased in 
neuronal differentiation is colocalized with neuro-
filament at the contacts of outgrowing neuritis.
Discussion
The synaptogenesis is a critical event in the deve-
lopment of the neuronal retina. Although sponta-
neous activity through gap junctions occurs in the 
retina before first chemical synapses appear (Cook 
et al., 1995; Wong et al., 1998), the vertical 
pathway to carry the main visual information from 
photoreceptors via bipolar cells to ganglion cells is 
composed of chemical synapses (Maslim et al., 
1986). Therefore, chemical transmission via neuro-
transmitters is the major form of signal flow in the 
retina. The main neurotransmitters in the verte-
brate retina are glutamate, GABA and glycine 
(Brandsta ̈tter et al., 1998; Wa ̈ssle et al., 1998). The 
differential expression of neurotransmitter recep-
tors among retinal neurons significantly adds to 
functional diversity for visual information (Yang, 
2004). 
    Shank proteins are major components of the 
postsynaptic density and display several protein- 
protein interaction domains (Sheng et al., 2000), 
which are the master scaffolding proteins in exci-
tatory postsynaptic region (Sheng, 2001). Gluta-
mate is the principal excitatory neurotransmitter in 
retinal synaptic circuitry (Brandsta ̈tter et al., 1998). 
By linking various glutamate receptors and intra-
cellular signaling proteins, Shank enhances the 
signal transmission and regulates the differen-
tiation or synaptogenesis of neuron (Ozma et al., 
1998; Sala et al., 2001; Roussignol et al., 2005; 
Gerrow et al., 2006). Among three members of the 
Shank family, we focused our studies on Shank 2 
because the role of Shank 2 in neuronal differen-
tiation of the developing retina remains to be 
elucidated though the expression of Shank 2 in 
retina synapses has been known (Brandsta ̈tter et 
al., 2004). 
    In the present study, we demonstrated Shank 2 
is expressed in the developing retina, which is 
related to the neuronal differentiation. Shank 2 was 
initially detected by P2 in the inner plexiform layer. 
As development progressed, Shank 2 was inten-
sely expressed in inner plexiform layer, outer plexi-
form layer, and ganglion cell layer with emergence 
of the outer plexiform layer and neuronal matura-
tion. Interestingly, Shank 2 is expressed in the 
plexiform layers even before the completion of 
plexiform layer formation, and also closely related 
with neurofilament expression during all the deve-
lopmental stages of retina. Based on the facts that 
synapses of retinal neurons are formed in the 
plexiform layers and the expression of neurofila-
ment is critical in neuronal differentiation, our 
results suggest that Shank 2 might be involved in 
the neuronal development and differentiation in 
retina. Shank 2 was colocalized exclusively with 
neurofilament of neuronal differentiation marker, 
but not with GFAP of an astrocyte-specific marker. 
With differentiation of retinoblastoma cells, Shank 
2 was up-regulated with neuronal differentiation 
mediated by ERK 1/2 activation. Moreover, Shank 
2 expression was colocalized with neurofilament at 
the contacts of outgrowing neurites from differen-
tiated retinoblastoma cells.
    In conclusion, our data suggests that Shank 2 is 
expressed in the neurons of developing retina and 
could play a critical role in the neuronal differen-
tiation of the developing retina. In the future, further 
studies about the coordinated regulation of Shank 
2 and other neurotrophic factors such as neurotro-
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phins and insulin growth factor-1 (Bovolenta et al., 
1996; Frade et al., 1996) in the retina could help 
not only to understand the mechanism of retinal 
neuronal differentiation and synapsis to join indi-
vidual neurons into a functional network of the 
retina, but also to develop therapeutic approaches 




C57BL/6 mice were purchased from Samtako (Korea). 
Care, use, and treatment of all animals in this study were 
in strict agreement with the ARVO statement for the Use of 
Animals in Ophthalmic and Vision Research. C57BL/6 
mice were kept in the condition of a standard 12-h dark 
light cycles and in around 23oC of room temperature. Eyes 
for normal retinal development experiments were enu-
cleated from C57BL/6 mice sacrificed on P2, P4, P8, and 
P14. Each group contained 10 animals.
Cell culture
The human retinoblastoma cells, SNUOT-Rb1, which was 
newly established by our group (Kim et al., 2007a, b), were 
cultured in RPMI-1640 containing penicillin-streptomycin (10 
ml/l, Gibco BRL, Invitrogen, CA) and 10% FBS (Gibco BRL, 
Invitrogen, CA) in 5% CO2 incubator at 37oC. The culture 
medium was changed every third day. To induce diffe-
rentiation of cells, all-trans retinoic acid (10 μM) was supplied 
into the culture media up to 10 days. The cultured cells were 
observed daily under a phase-contrast microscope.
Immunohistochemistry
The enucleated mouse eyes used for immunohistoche-
mistry were immersion fixed in 4% formaldehyde for 15 
min at room temperature and subsequently submerged 
into O.C.T. compound (Sakura Finetechnical Co. Ltd. Tokyo, 
Japan) followed by freezing at -80oC. 8 μm-thick serial 
sections were prepared from frozen blocks. The sections 
were incubated with the primary antibodies in a humidified 
chamber overnight. The following primary antibodies were 
used; goat anti-Shank 2 (1:100, Santa-Cruz Biotechnology, 
Santa Cruz, CA), rabbit anti-neurofilament (1:100, Che-
micon, Temecula, CA), rabbit anti-GFAP (1:100, Dako, 
Sanfrancisco, CA). Alexa Fluor 546 donkey anti-goat IgG 
(1:400, Molecular probes, Eugene, OR), Alexa Fluor 488 
donkey anti-rabbit IgG (1:400, Molecular probes, Eugene, 
OR) were used as secondary antibodies. The nuclei were 
stained with 4', 6-diamidino-2-phenolindole (DAPI, Sigma- 
Aldrich Co., St. Louis, MO). The slides were mounted with 
Faramount Aqueous mounting medium (DAKO, Glostrup, 
Denmark) and observed under fluorescence microscope 
(BX16, Olymphus, Tokyo, Japan).
Western blotting analysis
Western blotting was performed using standard western 
blotting methods. The protein concentration in the cytosolic 
fraction was measured using a BCA protein assay kit 
(Pierce, Rockford, IL). For western blot analysis, anti-Shank 
2 (Santa-Cruz Biotechnology, Santa Cruz, CA), anti-neuro-
filament (Chemicon, Temecula, CA), phospho-ERK1/2, or 
ERK1/2 (Cell Signaling Technology, Beverly, MA) antibo-
dies were used at the concentration of 1:1000, and 
HRP-conjugated anti-rabbit IgG or anti-mouse IgG were 
used at 1:5000 dilution. To ensure the equal loading of 
protein in each lane, the blots were stripped and reprobed 
with an antibody against β-actin. The blots were scanned 
using a flatbed scanner.
Immunocytochemistry
SNUOT-Rb1 Cells were grown and seeded on Deckglaser 
coverslips (Carolina Biological, Burlington, NC). Retino-
blastoma cells were fixed in 4% paraformaldehyde for over 
night at 4oC. The primary antibodies were diluted in PBS 
and added to the specimen followed by incubation for over 
night at room temperature. The following primary anti-
bodies were used; goat anti-Shank 2 (1:100, Santa-Cruz 
Biotechnology, Santa Cruz, CA), and rabbit anti-neurofila-
ment (1:100, Chemicon, Temecula, CA). Alexa Fluor 546 
donkey anti-goat IgG (1:400, Molecular probes, Eugene, 
OR), Alexa Fluor 488 donkey anti-rabbit IgG (1:400, Mole-
cular probes, Eugene, OR) were used as secondary 
antibodies. The nuclei were stained with 4’, 6-diamidino- 
2-phenolindole (DAPI, Sigma-Aldrich Co., St. Louis, MO). 
The slides were mounted with Faramount Aqueous moun-
ting medium (DAKO, Glostrup, Denmark) and observed 
under fluorescence microscope (Axio observer, Carl Zeiss, 
Chester, VA).
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